(1R,3S)-N-(4-(benzo[d]oxazol-2-yl)phenyl)-3-(2-methoxyacetamido)-N-methylcyclopentanecarboxamide

ID: ALA1834195

Chembl Id: CHEMBL1834195

PubChem CID: 56675411

Max Phase: Preclinical

Molecular Formula: C23H25N3O4

Molecular Weight: 407.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1

Standard InChI:  InChI=1S/C23H25N3O4/c1-26(23(28)16-7-10-17(13-16)24-21(27)14-29-2)18-11-8-15(9-12-18)22-25-19-5-3-4-6-20(19)30-22/h3-6,8-9,11-12,16-17H,7,10,13-14H2,1-2H3,(H,24,27)/t16-,17+/m1/s1

Standard InChI Key:  BOPUZXPMNOAYAM-SJORKVTESA-N

Associated Targets(Human)

FASN Tchem Fatty acid synthase (3390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.47Molecular Weight (Monoisotopic): 407.1845AlogP: 3.39#Rotatable Bonds: 6
Polar Surface Area: 84.67Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.16CX LogP: 2.27CX LogD: 2.27
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.68Np Likeness Score: -1.59

References

1. Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N..  (2011)  Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.,  21  (19): [PMID:21873051] [10.1016/j.bmcl.2011.07.083]
2.  (2017)  Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use,